High frequency of genital lichen sclerosus in a prospective series of 76 patients with morphea: Toward a better understanding of the spectrum of morphea

Archives of Dermatology

Volumn 148, Issue 1, 2012, Pages 24-28

  Lutz, Virginie ^a   Francès, Camille ^a,b   Bessis, Didier ^a,c   Cosnes, Anne ^a,d   Kluger, Nicolas ^e   Godet, Julien ^a   Sauleau, Erik ^a   Lipsker, Dan ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b HÔPITAL TENON   (France)

^c UNIV MONTPELLIER   (France)

^d HENRI MONDOR HOSPITAL   (France)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GENITAL PRURITUS; GENITAL SYSTEM DISEASE; GENITAL SYSTEM EXAMINATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LICHEN SCLEROSUS ET ATROPHICUS; MAJOR CLINICAL STUDY; MALE; MORPHEA; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEX DIFFERENCE; SKIN BIOPSY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; GENITAL DISEASES, FEMALE; GENITAL DISEASES, MALE; HUMANS; LICHEN SCLEROSUS ET ATROPHICUS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SCLERODERMA, LOCALIZED; YOUNG ADULT;

EID: 84856019639     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2011.305     Document Type: Article

References (41)

1. Powell JJ, Wojnarowska F. Lichen sclerosus. Lancet. 1999;353(9166):1777- 1783. (Pubitemid 29240387)
2. Peterson LS, Nelson AM, Su WP, Mason T, O'Fallon WM, Gabriel SE. The epidemiology of morphea (localized scleroderma) in Olmsted County 1960-1993. J Rheumatol. 1997;24(1):73-80. (Pubitemid 27059861)
3. Aberer E, Stanek G, Ertl M, Neumann R. Evidence for spirochetal origin of circumscribed scleroderma (morphea). Acta Derm Venereol. 1987;67(3):225-231. (Pubitemid 17084984)
4. Eisendle K, Grabner T, Zelger B. Focus floating microscopy: "gold standard" for cutaneous borreliosis? Am J Clin Pathol. 2007;127(2):213-222. (Pubitemid 46797178)
5. Eisendle K, Grabner T, Zelger B. Morphoea: amanifestation of infection with Borrelia species? Br J Dermatol. 2007;157(6):1189-1198. (Pubitemid 350115703)
6. Buechner SA, Winkelmann RK, Lautenschlager S, Gilli L, Rufli T. Localized scleroderma associated with Borrelia burgdorferi infection: clinical, histologic, and immunohistochemical observations. J Am Acad Dermatol. 1993;29(2, pt 1):190-196. (Pubitemid 23221896)
7. Schempp C, Bocklage H, Lange R, Kölmel HW, Orfanos CE, Gollnick H. Further evidence for Borrelia burgdorferi infection in morphea and lichen sclerosus et atrophicus confirmed by DNA amplification. J Invest Dermatol. 1993;100(5):717-720. (Pubitemid 23128372)
8. Lecerf V, Bagot M, Revuz J, Touraine R, Dournon E. Borrelia burgdorferi and localized scleroderma. Arch Dermatol. 1989;125(2):297.
9. Meis JF, Koopman R, van Bergen B, Pool G, Melchers W. No evidence for a relation between Borrelia burgdorferi infection and old lesions of localized scleroderma (morphea). Arch Dermatol. 1993;129(3):386-387. (Pubitemid 23077470)
10. Dillon WI, Saed GM, Fivenson DP. Borrelia burgdorferi DNA is undetectable by polymerase chain reaction in skin lesions of morphea, scleroderma, or lichen sclerosus et atrophicus of patients from North America. J Am Acad Dermatol. 1995;33(4):617-620.
11. Wienecke R, Schlüpen EM, Zöchling N, Neubert U, Meurer M, Volkenandt M. No evidence for Borrelia burgdorferi-specific DNA in lesions of localized scleroderma. J Invest Dermatol. 1995;104(1):23-26.
12. Weide B, Schittek B, Klyscz T, et al. Morphoea is neither associated with features of Borrelia burgdorferi infection, nor is this agent detectable in lesional skin by polymerase chain reaction. Br J Dermatol. 2000;143(4):780-785.
13. De Vito JR, Merogi AJ, Vo T, et al. Role of Borrelia burgdorferi in the pathogenesis of morphea/scleroderma and lichen sclerosus et atrophicus: a PCR study of thirty-five cases. J Cutan Pathol. 1996;23(4):350-358. (Pubitemid 26273331)
14. Sherman V, McPherson T, Baldo M, Salim A, Gao XH, Wojnarowska F. The high rate of familial lichen sclerosus suggests a genetic contribution: an observational cohort study. J Eur Acad Dermatol Venereol. 2010;24(9):1031-1034.
15. Gao XH, Barnardo MC, Winsey S, et al. The association between HLA DR, DQ antigens, and vulval lichen sclerosus in the UK: HLA DRB112 and its associated DRB112/DQB10301/04/09/010 haplotype confers susceptibility to vulval lichen sclerosus, and HLA DRB10301/04 and its associated DRB10301/04/DQB10201/02/03 haplotype protects from vulval lichen sclerosus. J Invest Dermatol. 2005;125(5):895-899.
16. Leitenberger JJ, Cayce RL, Haley RW, Adams-Huet B, Bergstresser PR, Jacobe HT. Distinct autoimmune syndromes in morphea: a review of 245 adult and pediatric cases. Arch Dermatol. 2009;145(5):545-550.
17. Majeed M, Al-Mayouf SM, Al-Sabban E, Bahabri S. Coexistent linear scleroderma and juvenile systemic lupus erythematosus. Pediatr Dermatol. 2000;17(6):456-459. (Pubitemid 32039306)
18. Bonifati C, Impara G, Morrone A, Pietrangeli A, Carducci M. Simultaneous occurrence of linear scleroderma and homolateral segmental vitiligo. J Eur Acad Dermatol Venereol. 2006;20(1):63-65.
19. Meyrick Thomas RH, Ridley CM, McGibbon DH, Black MM. Lichen sclerosus et atrophicus and autoimmunity - a study of 350 women. Br J Dermatol. 1988;118(1):41-46.
20. Aslanian FM, Marques MT, Matos HJ, et al. HLA markers in familial lichen sclerosus. J Dtsch Dermatol Ges. 2006;4(10):842-847. (Pubitemid 44434327)
21. Barete S, Lipsker D, Francès C. Morphées. In: Allanore Y, Cabane J, Mouthon L, eds. Sclérodermies [in French]. 2nd ed. Paris, France: Med-Line; 2011:209-226.
22. Peterson LS, Nelson AM, SuWP. Classification of morphea (localized scleroderma). Mayo Clin Proc. 1995;70(11):1068-1076.
23. Sehgal VN, Srivastava G, Aggarwal AK, Behl PN, Choudhary M, Bajaj P. Localized scleroderma/morphea. Int J Dermatol. 2002;41(8):467-475. (Pubitemid 35021484)
24. Puzenat E, Humbert Ph, Aubin F. Sclérodermies localisées: les morphées. In: Saurat JH, Lachapelle JM, Lipsker D, Thomas L, eds. Dermatologie et Infections Sexuellement Transmissibles [in French]. 5th ed. Paris, France: Masson; 2009:364-374.
25. Freedberg IM, Eisen AZ, Wolff K, et al. Scleroderma. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz S, eds. Fitzpatrick's Dermatology in General Medicine. Vol 1. 3rd ed. New York, NY: McGraw-Hill; 1999:1842-1850.
26. Champion RH, Burton JL, Burns DA, Breathnach SM. Perniosis: localized morphea. In: Rook A, Wilkinson DS, Ebling FJG, eds. Rook-Wilkinson-Ebling Textbook of Dermatology. Vol 3. 6th ed. Oxford, England: Blackwell Science Ltd; 1998:2502-2512.
27. Yu BD, Eisen AZ. Morphea. In: Freedberg IM, Eisen AZ, Wolff K, Austen FK, Goldsmith LA, Katz S, eds. In: Fitzpatrick's Dermatology in General Medicine. Vol II. 6th ed. New York, NY: McGraw-Hill; 2010:1709-1718.
28. Derrick EK, Ridley CM, Kobza-Black A, McKee PH, Neill SM. A clinical study of 23 cases of female anogenital carcinoma. Br J Dermatol. 2000;143(6):1217-1223. (Pubitemid 32052758)
29. Sergeant A, Vernall N, Mackintosh LJ, McHenry P, Leman JA. Squamous cell carcinoma arising in extragenital lichen sclerosus. Clin Exp Dermatol. 2009; 34(7):e278-e279. doi:10.1111/j.1365-2230.2008.03195.x.
30. Wang SH, Chi CC, Wong YW, Salim A, Manek S, Wojnarowska F. Genital verrucous carcinoma is associated with lichen sclerosus: a retrospective study and review of the literature. J Eur Acad Dermatol Venereol. 2010;24(7):815-819.
31. Cooper SM, Gao XH, Powell JJ, Wojnarowska F. Does treatment of vulvar lichen sclerosus influence its prognosis? Arch Dermatol. 2004;140(6):702-706. (Pubitemid 38747286)
32. Pugliese JM, Morey AF, Peterson AC. Lichen sclerosus: review of the literature and current recommendations for management. J Urol. 2007;178(6):2268-2276. (Pubitemid 350052170)
33. van de Nieuwenhof HP, van der Avoort IA, de Hullu JA. Review of squamous premalignant vulvar lesions. Crit Rev Oncol Hematol. 2008;68(2):131-156.
34. Tremaine R, Adam JE, Orizaga M. Morphea coexisting with lichen sclerosus et atrophicus. Int J Dermatol. 1990;29(7):486-489. (Pubitemid 20293313)
35. Farrell AM, Marren PM, Wojnarowska F. Genital lichen sclerosus associated with morphoea or systemic sclerosis: clinical and HLA characteristics. Br J Dermatol. 2000;143(3):598-603.
36. Wu KH, Dai YS, Tsai MJ, et al. Lichen sclerosus et atrophicus, bullous morphea, and systemic lupus erythematosus: a case report. J Microbiol Immunol Infect. 2000;33(1):53-56.
37. Kim DH, Lee KR, Kim TY, Yoon MS. Coexistence of lichen sclerosus with morphoea showing bilateral symmetry. Clin Exp Dermatol. 2009;34(7):e416-e418. doi:10.1111/j.1365-2230.2009.03396.x.
38. Connelly MG, Winkelmann RK. Coexistence of lichen sclerosus, morphea, and lichen planus: report of four cases and review of the literature. JAmAcad Dermatol. 1985;12(5, pt 1):844-851.
39. Sawamura D, Yaguchi T, Hashimoto I, Nomura K, Konta R, Umeki K. Coexistence of generalized morphea with histological changes in lichen sclerosus et atrophicus and lichen planus. J Dermatol. 1998;25(6):409-411. (Pubitemid 28345677)
40. Mensing H, Schmidt KU. Diffuse fasciitis with eosinophilia associated with morphea and lichen sclerosus et atrophicus. Acta Derm Venereol. 1985;65(1):80-83. (Pubitemid 15153819)
41. Lampert A, Fortier-Beaulieu M, Thomine E, Young P, Lauret P. Association sur un membre d'un lichen scléreux et d'une sclérodermie monomélique [association of lichen sclerosus and monomelic scleroderma] [in French]. Ann Dermatol Venereol. 1995;122(3):102-104.